MY114610A - Controlled drug delivery system for diltiazem. - Google Patents
Controlled drug delivery system for diltiazem.Info
- Publication number
- MY114610A MY114610A MYPI98005480A MYPI19985480A MY114610A MY 114610 A MY114610 A MY 114610A MY PI98005480 A MYPI98005480 A MY PI98005480A MY PI19985480 A MYPI19985480 A MY PI19985480A MY 114610 A MY114610 A MY 114610A
- Authority
- MY
- Malaysia
- Prior art keywords
- diltiazem
- weight
- polymer
- delivery system
- drug delivery
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET OR A CAPSULE FOR THE CONTROLLED RELEASE OF DILTIAZEM, COMPRISES ABOUT 30 TO ABOUT 97BY WEIGHT OF A HYDROPHILIC POLYMER, ABOUT 0.5 TO ABOUT 30BY WEIGHT OF AN ENTERIC (PH-DEPENDENT) POLYMER, AND ABOUT 2.5 TO ABOUT 60BY WEIGHT OF DILTIAZEM OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEREOF. THE RATIO OF HYDROPHILIC POLYMER TO ENTERIC POLYMER IS IN THE RANGE OF ABOUT 1:1 TO ABOUT 15:1. SUCH A PHARMACEUTICAL COMPOSITION RELEASES DILTIAZEM AT A RATE THAT ALLOWS EFFECTIVE PLASMA LEVELS OF DILTIAZEM TO BE MAINTAINED OVER A PERIOD OF TWENTY-FOUR HOURS AFTER ADMINISTRATION TO HUMAN ADULT SUBJECTS. FIGURE 1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/984,733 US6074669A (en) | 1997-01-20 | 1997-12-04 | Controlled drug delivery system for diltiazem |
Publications (1)
Publication Number | Publication Date |
---|---|
MY114610A true MY114610A (en) | 2002-11-30 |
Family
ID=25530809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI98005480A MY114610A (en) | 1997-12-04 | 1998-12-03 | Controlled drug delivery system for diltiazem. |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1166364C (en) |
AU (1) | AU9521398A (en) |
MY (1) | MY114610A (en) |
SG (1) | SG74102A1 (en) |
-
1998
- 1998-12-03 AU AU95213/98A patent/AU9521398A/en not_active Abandoned
- 1998-12-03 MY MYPI98005480A patent/MY114610A/en unknown
- 1998-12-04 SG SG1998005173A patent/SG74102A1/en unknown
- 1998-12-04 CN CNB981267181A patent/CN1166364C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1237417A (en) | 1999-12-08 |
AU9521398A (en) | 1999-06-24 |
CN1166364C (en) | 2004-09-15 |
SG74102A1 (en) | 2000-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA29563C2 (en) | Microcapsule for prolonged release of physiologically active peptide | |
MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
NZ508526A (en) | Opioid formulations for treating pain | |
MX9804008A (en) | Pharmaceutical formulations. | |
LV10684B (en) | Controlled release preparation containing a salt of morphine | |
ATE246505T1 (en) | PREPARATION CONTAINING CEFACLOR OR CEPHALEXIN WITH MODIFIED RELEASE MATRIX | |
IL118240A (en) | Oral coated capsule dosage form of omega-3 polyunsaturated acid for release of the acid in the intestine | |
IL109770A0 (en) | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby | |
CA2025703A1 (en) | Pulsatile once-a-day delivery systems for minocycline | |
ATE248589T1 (en) | MATRIX FOR THE CONTROLLED RELEASE OF MEDICINAL SUBSTANCES | |
IL209703A0 (en) | Controlled release hydrocodone formulations | |
EP0225189A3 (en) | Targeted enteral delivery system | |
PL324402A1 (en) | Preparation of controllable release of slightly coluble drugs contained therein | |
IE970588A1 (en) | Controlled release pharmaceutical compositions containing tiagabine | |
GR3036798T3 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
NO962752L (en) | Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis | |
MY114610A (en) | Controlled drug delivery system for diltiazem. | |
DE69634080D1 (en) | MEANS OF PREVENTING THE TURNING OF THE FRONT LENS CAPSULE | |
EP0649660A3 (en) | Pharmaceutical composition for parenteral, enteral and dermal administration of essentially insoluble drugs and process for their preparation. | |
PL317996A1 (en) | Carbamazepinic form of a drug with retarded release of biologically active substance | |
CA2356306A1 (en) | Sulfated phosphatidylinositols, their preparation and use | |
CA2187153A1 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
TH52205A (en) | Controlled drug delivery system for diltiazem |